Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.41 -0.01 (-0.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Goodwill (2023 - 2026)

Updated

Cartesian Therapeutics (RNAC) recorded Goodwill of $48.16 million in Q2 2026, unchanged from $48.16 million a year earlier and unchanged from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) Goodwill (2023 - 2026) Analysis & Trends

Starting with Q4 2023, Cartesian Therapeutics' Goodwill history includes 11 quarters.

  • Across earlier years, Goodwill came in at $48.16 million in FY2024 (unchanged) and $48.16 million in FY2023.
  • Per Business Quant, the preceding three quarters came in at $48.16 million (Q1 2026), $48.16 million (Q4 2025) and $48.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Cartesian Therapeutics 188.59 Mn -346.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.16 Mn
Mar 31, 2026 48.16 Mn
Dec 31, 2025 48.16 Mn
Sep 30, 2025 48.16 Mn
Jun 30, 2025 48.16 Mn
Mar 31, 2025 48.16 Mn
Dec 31, 2024 48.16 Mn
Sep 30, 2024 48.16 Mn
Jun 30, 2024 48.16 Mn
Mar 31, 2024 48.16 Mn
Dec 31, 2023 48.16 Mn
API Access

Cartesian Therapeutics Goodwill API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill&ticker=RNAC&period=max&api_key=YOUR_API_KEY